SMART researchers uncover new anti-phage defense mechanisms
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
The Audacious Project commitment will support the development of new classes of antibiotics to treat the world’s deadliest bacterial pathogens.
An eminent microbiologist, Demain conducted groundbreaking antibiotics research and mentored hundreds of young scientists.
Microfluidics enables researchers to create unique environment for developing medicine, paving the way for more potent, high-quality drugs.
Deborah Hung shares research strategies to combat tuberculosis as part of the Department of Biology's IAP seminar series on microbes in health and disease.
Polymer may pave the way for drugs to which bacteria are significantly less resistant, a breakthrough that could save hundreds of thousands of lives per year.
By tweaking bacteriophage genomes, MIT team creates a new weapon to combat infection.
Drawn to MIT by its “amazing women who were doing science,” Professor Laura Kiessling explores sugar-protein interactions that influence cell behavior.
Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.
Simple method for linking molecules could help overcome drug resistant infections.
Delivered together, the two join forces to eradicate drug-resistant bacteria.
With aid of computer algorithm, researchers develop peptides more powerful than those found in nature.
Antimicrobial peptides can kill strains resistant to existing antibiotics.
Shortwave infrared instrument from MIT could see deeper, help improve diagnosis of ear infections.
Strains of E. coli resistant to one antibiotic can protect other bacteria growing nearby.